The systemic repair peptide. A 43-amino acid fragment of Thymosin Beta-4, naturally produced by the thymus gland. Studied for its role in angiogenesis, wound healing, and anti-inflammatory response. Often stacked with BPC-157 for synergistic tissue repair.
TB-500 is under regulatory review in India. We're working with our physician network to bring this protocol to arq once sourcing and compliance are confirmed.
TB-500 (Thymosin Beta-4) is a naturally occurring polypeptide with significant implications for tissue repair and regeneration. The peptide has been extensively studied in both systemic and localized applications, showing remarkable effects on cellular migration, angiogenesis, and anti-inflammatory pathways.
TB-500 has been the subject of significant preclinical and clinical research, particularly in musculoskeletal and cardiac tissue repair. The evidence demonstrates its utility in accelerating healing timelines and improving tissue quality.
We're working on sourcing and compliance. Join the waitlist and we'll notify you the moment TB-500 becomes available on arq.